REGONOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Regonol, and when can generic versions of Regonol launch?
Regonol is a drug marketed by Sandoz and is included in one NDA.
The generic ingredient in REGONOL is pyridostigmine bromide. There are eleven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the pyridostigmine bromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Regonol
A generic version of REGONOL was approved as pyridostigmine bromide by IMPAX LABS on April 24th, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for REGONOL?
- What are the global sales for REGONOL?
- What is Average Wholesale Price for REGONOL?
Summary for REGONOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 151 |
| Clinical Trials: | 1 |
| Patent Applications: | 3,448 |
| Drug Prices: | Drug price information for REGONOL |
| What excipients (inactive ingredients) are in REGONOL? | REGONOL excipients list |
| DailyMed Link: | REGONOL at DailyMed |
Recent Clinical Trials for REGONOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Early Phase 1 |
| Icahn School of Medicine at Mount Sinai | Early Phase 1 |
| National Institutes of Health (NIH) | Early Phase 1 |
Pharmacology for REGONOL
| Drug Class | Cholinesterase Inhibitor |
| Mechanism of Action | Cholinesterase Inhibitors |
US Patents and Regulatory Information for REGONOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | REGONOL | pyridostigmine bromide | INJECTABLE;INJECTION | 017398-001 | Approved Prior to Jan 1, 1982 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
